VIB Vermögen AG

XTRA:VIH1 Stock Report

Market Cap: €325.3m

VIB Vermögen Future Growth

Future criteria checks 0/6

VIB Vermögen's earnings are forecast to decline at 19.3% per annum while its annual revenue is expected to grow at 2.8% per year. EPS is expected to decline by 19.2% per annum. Return on equity is forecast to be 6.7% in 3 years.

Key information

-19.3%

Earnings growth rate

-19.2%

EPS growth rate

Real Estate earnings growth96.2%
Revenue growth rate2.8%
Future return on equity6.7%
Analyst coverage

Low

Last updated22 Aug 2024

Recent future growth updates

VIB Vermögen AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Feb 18
VIB Vermögen AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Recent updates

Should You Think About Buying VIB Vermögen AG (ETR:VIH1) Now?

Oct 11
Should You Think About Buying VIB Vermögen AG (ETR:VIH1) Now?

VIB Vermögen AG (ETR:VIH1) Shares Fly 26% But Investors Aren't Buying For Growth

Sep 20
VIB Vermögen AG (ETR:VIH1) Shares Fly 26% But Investors Aren't Buying For Growth

Concerns Surrounding VIB Vermögen's (ETR:VIH1) Performance

May 08
Concerns Surrounding VIB Vermögen's (ETR:VIH1) Performance

When Should You Buy VIB Vermögen AG (ETR:VIH1)?

Dec 20
When Should You Buy VIB Vermögen AG (ETR:VIH1)?

Is VIB Vermögen (ETR:VIH1) Using Too Much Debt?

Jun 21
Is VIB Vermögen (ETR:VIH1) Using Too Much Debt?

Is Now The Time To Look At Buying VIB Vermögen AG (ETR:VIH1)?

May 30
Is Now The Time To Look At Buying VIB Vermögen AG (ETR:VIH1)?

VIB Vermögen AG (ETR:VIH1) Shares Could Be 43% Below Their Intrinsic Value Estimate

Mar 29
VIB Vermögen AG (ETR:VIH1) Shares Could Be 43% Below Their Intrinsic Value Estimate

VIB Vermögen AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Feb 18
VIB Vermögen AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Is It Too Late To Consider Buying VIB Vermögen AG (ETR:VIH1)?

Feb 11
Is It Too Late To Consider Buying VIB Vermögen AG (ETR:VIH1)?

Is It Too Late To Consider Buying VIB Vermögen AG (ETR:VIH1)?

Sep 06
Is It Too Late To Consider Buying VIB Vermögen AG (ETR:VIH1)?

Is VIB Vermögen (ETR:VIH1) A Risky Investment?

Oct 15
Is VIB Vermögen (ETR:VIH1) A Risky Investment?

VIB Vermögen (ETR:VIH1) Has Compensated Shareholders With A Respectable 100% Return On Their Investment

Mar 11
VIB Vermögen (ETR:VIH1) Has Compensated Shareholders With A Respectable 100% Return On Their Investment

A Closer Look At VIB Vermögen AG's (ETR:VIH1) Impressive ROE

Feb 18
A Closer Look At VIB Vermögen AG's (ETR:VIH1) Impressive ROE

You Have To Love VIB Vermögen AG's (ETR:VIH1) Dividend

Jan 19
You Have To Love VIB Vermögen AG's (ETR:VIH1) Dividend

Here's What VIB Vermögen AG's (ETR:VIH1) Shareholder Ownership Structure Looks Like

Dec 25
Here's What VIB Vermögen AG's (ETR:VIH1) Shareholder Ownership Structure Looks Like

Shareholders Of VIB Vermögen (ETR:VIH1) Must Be Happy With Their 94% Return

Dec 06
Shareholders Of VIB Vermögen (ETR:VIH1) Must Be Happy With Their 94% Return

A Closer Look At VIB Vermögen AG's (ETR:VIH1) Impressive ROE

Nov 18
A Closer Look At VIB Vermögen AG's (ETR:VIH1) Impressive ROE

Earnings and Revenue Growth Forecasts

XTRA:VIH1 - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261014970951
12/31/20259242111971
12/31/20248538151041
6/30/202498876868N/A
3/31/20241001087272N/A
12/31/20231031307575N/A
9/30/20231051077373N/A
6/30/2023108847171N/A
3/31/202312876N/AN/AN/A
12/31/2022128546868N/A
9/30/202212641N/AN/AN/A
6/30/2022126497474N/A
3/31/2022106143N/AN/AN/A
12/31/2021102307575N/A
9/30/202110154N/AN/AN/A
6/30/202198536971N/A
3/31/20219671N/AN/AN/A
12/31/202094666465N/A
9/30/20209471N/AN/AN/A
6/30/202093676464N/A
3/31/20209264N/AN/AN/A
12/31/201991636969N/A
9/30/20199058N/AN/AN/A
6/30/201989606767N/A
3/31/20198859N/AN/AN/A
12/31/201887586161N/A
9/30/20188658N/AN/AN/A
6/30/201885536161N/A
3/31/20188551N/AN/AN/A
12/31/20178452N/A59N/A
9/30/20178349N/AN/AN/A
6/30/20178250N/A57N/A
3/31/20178150N/AN/AN/A
12/31/20168047N/A58N/A
9/30/20167943N/AN/AN/A
6/30/20167844N/A56N/A
3/31/20167740N/AN/AN/A
12/31/20157540N/A54N/A
9/30/20157337N/AN/AN/A
6/30/20157232N/AN/AN/A
3/31/20157132N/AN/AN/A
12/31/20147031N/A48N/A
9/30/20146929N/AN/AN/A
6/30/20146828N/AN/AN/A
3/31/20146627N/AN/AN/A
12/31/20136527N/A48N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: VIH1's earnings are forecast to decline over the next 3 years (-19.3% per year).

Earnings vs Market: VIH1's earnings are forecast to decline over the next 3 years (-19.3% per year).

High Growth Earnings: VIH1's earnings are forecast to decline over the next 3 years.

Revenue vs Market: VIH1's revenue (2.8% per year) is forecast to grow slower than the German market (5.7% per year).

High Growth Revenue: VIH1's revenue (2.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: VIH1's Return on Equity is forecast to be low in 3 years time (6.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 00:45
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

VIB Vermögen AG is covered by 13 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Andre RemkeBaader Helvea Equity Research
Gerhard SchwarzBaader Helvea Equity Research
Paul MayBarclays